Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: GlobalData | PRODUCT CODE: 1766821

Cover Image

PUBLISHER: GlobalData | PRODUCT CODE: 1766821

Spain Oncology Market Outlook to 2033 - Colorectal Cancer Screening Tests, EGFR Tests, KRAS Tests and Others

PUBLISHED:
PAGES: 150 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 4995
PDF (Site License)
USD 9990
PDF (Global License)
USD 14985

Add to Cart

GlobalData's "Spain Oncology Market Outlook to 2033" is a comprehensive databook report, covering key market data on the Spain Oncology market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments - Colorectal Cancer Screening Tests, EGFR Tests, KRAS Tests, HER2 Tests, BRCA Tests, ALK Tests, BRAF Tests, BCR-ABL Tests and PD-L1 Tests

The Spain Oncology Market report provides key information and data on -

  • Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2018 to 2033.
  • 2024 company share data for Oncology Market.
  • Global corporate-level profiles of key companies operating within the Spain Oncology Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.

Scope

Spain Oncology is segmented as follows -

  • Colorectal Cancer Screening Tests
  • EGFR Tests
  • KRAS Tests
  • HER2 Tests
  • BRCA Tests
  • ALK Tests
  • BRAF Tests
  • BCR-ABL Tests
  • PD-L1 Tests

Reasons to Buy

The Spain Oncology Market report helps you to develop -

  • Business strategies by identifying the key market segments poised for strong growth in the future.
  • Market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • Understand the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.
Product Code: GDME25624CCDB

Table of Contents

1 Table of Contents

  • 1.1 List of Tables
  • 1.2 List of Figures

2 Introduction

  • 2.1 What Is This Report About?
  • 2.2 Oncology Market Segmentation
  • 2.3 Definitions of Markets Covered in the Report

3 Oncology Market, Spain

  • 3.1 Oncology Market, Spain, Revenue ($m), 2018-2033
    • 3.1.1 ALK Tests Market, Spain, Revenue ($m), by Segment, 2018-2033
    • 3.1.2 BCR-ABL Tests Market, Spain, Revenue ($m), by Segment, 2018-2033
    • 3.1.3 BRAF Tests Market, Spain, Revenue ($m), by Segment, 2018-2033
    • 3.1.4 BRCA Tests Market, Spain, Revenue ($m), by Segment, 2018-2033
    • 3.1.5 Colorectal Cancer Screening Tests Market, Spain, Revenue ($m), by Segment, 2018-2033
    • 3.1.6 EGFR Tests Market, Spain, Revenue ($m), by Segment, 2018-2033
    • 3.1.7 HER2 Tests Market, Spain, Revenue ($m), by Segment, 2018-2033
    • 3.1.8 KRAS Tests Market, Spain, Revenue ($m), by Segment, 2018-2033
  • 3.2 Oncology Market, Spain, Volume (Units), 2018-2033
    • 3.2.1 ALK Tests Market, Spain, Volume (Units), by Segment, 2018-2033
    • 3.2.2 BCR-ABL Tests Market, Spain, Volume (Units), by Segment, 2018-2033
    • 3.2.3 BRAF Tests Market, Spain, Volume (Units), by Segment, 2018-2033
    • 3.2.4 BRCA Tests Market, Spain, Volume (Units), by Segment, 2018-2033
    • 3.2.5 Colorectal Cancer Screening Tests Market, Spain, Volume (Units), by Segment, 2018-2033
    • 3.2.6 EGFR Tests Market, Spain, Volume (Units), by Segment, 2018-2033
    • 3.2.7 HER2 Tests Market, Spain, Volume (Units), by Segment, 2018-2033
    • 3.2.8 KRAS Tests Market, Spain, Volume (Units), by Segment, 2018-2033
  • 3.3 Oncology Market, Spain, Average Price ($) , 2018-2033
  • 3.4 Oncology Market, Spain, Company Share by Revenue ($m), 2024

4 Overview of Key Companies in Spain, Oncology Market

  • 4.1 F. Hoffmann-La Roche Ltd
    • 4.1.1 Company Overview
  • 4.2 Agilent Technologies Inc
    • 4.2.1 Company Overview
  • 4.3 Qiagen NV
    • 4.3.1 Company Overview
  • 4.4 Abbott Laboratories
    • 4.4.1 Company Overview
  • 4.5 Danaher Corp
    • 4.5.1 Company Overview
  • 4.6 Resonac Corporation
    • 4.6.1 Company Overview
  • 4.7 Eiken Chemical Co Ltd
    • 4.7.1 Company Overview
  • 4.8 Alfresa Pharma Corp
    • 4.8.1 Company Overview
  • 4.9 BioGenex Laboratories Inc
    • 4.9.1 Company Overview
  • 4.10 Amoy Diagnostics Co Ltd
    • 4.10.1 Company Overview

5 Oncology Market Pipeline Products

6 Financial Deals Landscape

  • 6.1 Partnerships
    • 6.1.1 A. Menarini Diagnostics Enters into Distribution Agreement with Nucleix
  • 6.2 Private Equity
    • 6.2.1 Brookfield and Grifols Family May Acquire Grifols for USD5.95 Billion
  • 6.3 Venture Financing
    • 6.3.1 Universal Diagnostics SL (Universal DX) Secures Additional Series B Financing
    • 6.3.2 The Blue Box Biomedical Solutions Secures USD0.54 Million in Venture Financing

7 Recent Developments

  • 7.1 Corporate Communications
    • 7.1.1 Jun 28, 2024: ORYZON Announces Voting Results from its 2024 Annual General Meeting of Shareholders
  • 7.2 Government and Public Interest
    • 7.2.1 Jun 05, 2024: The 41st Barcelona Biomed Conference Reveals New Avenues For Cancer Prevention
  • 7.3 Other Significant Developments
    • 7.3.1 Mar 05, 2025: Atrys Chile and Interclinica Launch a New Telemedicine-Based Care Model to Reduce Stroke Response Time
    • 7.3.2 Dec 20, 2024: Atrys Health Reduces Medical Care Times in Chile by 88% Thanks to Telemedicine and AI
  • 7.4 Product News
    • 7.4.1 Feb 06, 2025: Researchers Develop a Device That Replicates Tumours to Study the Efficacy of Immunotherapy Treatments
    • 7.4.2 Nov 21, 2024: Researchers Identify Inflammatory Markers Related to the Prognosis of Breast Cancer
    • 7.4.3 Nov 12, 2024: Researchers Identify a Potential Biomarker of Parkinson's Disease Progression
    • 7.4.4 Oct 25, 2024: Scientists Identify Biomarkers in Semen Samples That Could Help Reduce Overdiagnosis in Prostate Cancer Screening
    • 7.4.5 Jul 15, 2024: A New Biomarker Shows Potential to Evaluate Treatment Response for Metastatic Colorectal Cancer
    • 7.4.6 Jul 15, 2024: Peptomyc S.L. Expands Patent Portfolio with European and Indian Patent Grant for its Methods and Composition for the Treatment of Cancer
    • 7.4.7 Jul 12, 2024: A New Bioinformatics Algorithm Improves the Genetic Detection of Lynch and CMMRD Syndromes
    • 7.4.8 Jul 09, 2024: Prostate Cancer Spreads by Sending Messages to Other Organs
    • 7.4.9 Jul 04, 2024: A Genetic Test Will Improve the Diagnosis of a Rare Cancer Predisposition Syndrome in Children
    • 7.4.10 Jul 01, 2024: Researchers Discover Biomarkers That Predict Response to Immunotherapy in Skin Carcinoma
    • 7.4.11 Jun 04, 2024: VHIO Researchers Demonstrate the Utility of Ultrasensitive Liquid Biopsy to Predict and Monitor Response to Immunotherapy

8 Appendix

  • 8.1 Research Methodology
    • 8.1.1 Coverage
    • 8.1.2 Secondary Research
    • 8.1.3 Primary Research
    • 8.1.4 Market Modeling and Forecasting
    • 8.1.5 Company Share Analysis
    • 8.1.6 Benchmarking
  • 8.2 GlobalData Consulting
  • 8.3 Contact Us
  • 8.4 Disclaimer
Product Code: GDME25624CCDB

List of Table

List of Tables

  • Table 1: Oncology Market, Spain, Revenue ($m), USD Constant, 2018-2033
  • Table 2: ALK Tests Market, Spain, Revenue ($m), USD Constant, 2018-2033
  • Table 3: BCR-ABL Tests Market, Spain, Revenue ($m), USD Constant, 2018-2033
  • Table 4: BRAF Tests Market, Spain, Revenue ($m), USD Constant, 2018-2033
  • Table 5: BRCA Tests Market, Spain, Revenue ($m), USD Constant, 2018-2033
  • Table 6: Colorectal Cancer Screening Tests Market, Spain, Revenue ($m), USD Constant, 2018-2033
  • Table 7: EGFR Tests Market, Spain, Revenue ($m), USD Constant, 2018-2033
  • Table 8: HER2 Tests Market, Spain, Revenue ($m), USD Constant, 2018-2033
  • Table 9: KRAS Tests Market, Spain, Revenue ($m), USD Constant, 2018-2033
  • Table 10: Oncology Market, Spain, Volume (Units), 2018-2033
  • Table 11: ALK Tests Market, Spain, Volume (Units), 2018-2033
  • Table 12: BCR-ABL Tests Market, Spain, Volume (Units), 2018-2033
  • Table 13: BRAF Tests Market, Spain, Volume (Units), 2018-2033
  • Table 14: BRCA Tests Market, Spain, Volume (Units), 2018-2033
  • Table 15: Colorectal Cancer Screening Tests Market, Spain, Volume (Units), 2018-2033
  • Table 16: EGFR Tests Market, Spain, Volume (Units), 2018-2033
  • Table 17: HER2 Tests Market, Spain, Volume (Units), 2018-2033
  • Table 18: KRAS Tests Market, Spain, Volume (Units), 2018-2033
  • Table 19: Oncology Market, Spain, Average Price ($), 2018-2033
  • Table 20: Oncology Market, Spain, Company Share by Revenue ($m), 2024
  • Table 21: Oncology Market Pipeline Products
  • Table 22: A. Menarini Diagnostics Enters into Distribution Agreement with Nucleix
  • Table 23: Brookfield and Grifols Family May Acquire Grifols for USD5.95 Billion
  • Table 24: Universal Diagnostics SL (Universal DX) Secures Additional Series B Financing
  • Table 25: The Blue Box Biomedical Solutions Secures USD0.54 Million in Venture Financing
  • Table 26: Total Number of Primary Research Participants, In Vitro Diagnostics Market, by Country

List of Figure

List of Figures

  • Figure 1: Oncology Market, Spain, Revenue ($m), USD Constant, 2018-2033
  • Figure 2: ALK Tests Market, Spain, Revenue ($m), USD Constant, 2018-2033
  • Figure 3: BCR-ABL Tests Market, Spain, Revenue ($m), USD Constant, 2018-2033
  • Figure 4: BRAF Tests Market, Spain, Revenue ($m), USD Constant, 2018-2033
  • Figure 5: BRCA Tests Market, Spain, Revenue ($m), USD Constant, 2018-2033
  • Figure 6: Colorectal Cancer Screening Tests Market, Spain, Revenue ($m), USD Constant, 2018-2033
  • Figure 7: EGFR Tests Market, Spain, Revenue ($m), USD Constant, 2018-2033
  • Figure 8: HER2 Tests Market, Spain, Revenue ($m), USD Constant, 2018-2033
  • Figure 9: KRAS Tests Market, Spain, Revenue ($m), USD Constant, 2018-2033
  • Figure 10: Oncology Market, Spain, Volume (Units), 2018-2033
  • Figure 11: ALK Tests Market, Spain, Volume (Units), 2018-2033
  • Figure 12: BCR-ABL Tests Market, Spain, Volume (Units), 2018-2033
  • Figure 13: BRAF Tests Market, Spain, Volume (Units), 2018-2033
  • Figure 14: BRCA Tests Market, Spain, Volume (Units), 2018-2033
  • Figure 15: Colorectal Cancer Screening Tests Market, Spain, Volume (Units), 2018-2033
  • Figure 16: EGFR Tests Market, Spain, Volume (Units), 2018-2033
  • Figure 17: HER2 Tests Market, Spain, Volume (Units), 2018-2033
  • Figure 18: KRAS Tests Market, Spain, Volume (Units), 2018-2033
  • Figure 19: Oncology Market, Spain, Company Share (%), 2024
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!